facebook-page-view
Advertisement

How TPG, Baring PE Asia’s two-year-old bets in pharma, IT are faring

By Ankit Agarwal

  • 11 May 2021
Premium
How TPG, Baring PE Asia’s two-year-old bets in pharma, IT are faring
Credit: Pixabay

TPG Growth, which has backed several traditional Indian healthcare companies ranging from hospitals to medical devices makers, is sitting on over 3x return on its two-year investment in an Indian bulk drugs maker. At the price at which it made the latest part-exit, TPG is sitting on 3.24x returns from Solara ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement